Tizanidine Hydrochloride Capsule
Product Images NDC 70771-1068

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 70771-1068). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ac68e443 89c9 42b1 Aa4c 66a32746d81e 01

Chemical structure diagram of tizanidine hydrochloride, showing the molecular composition and connectivity of atoms characteristic of this active ingredient.*

FDA Label Image

Ac68e443 89c9 42b1 Aa4c 66a32746d81e 02

A line graph comparing plasma tizanidine concentration (ng/mL) over 24 hours after dosing with 2x4 mg tizanidine tablets or capsules, either with or without food. The x-axis shows hours from dosing (0 to 24) and the y-axis shows plasma concentration, peaking near 5 ng/mL around 1-2 hours postdose. Four lines represent each formulation and condition according to a legend.*

FDA Label Image

Ac68e443 89c9 42b1 Aa4c 66a32746d81e 03

Line graph showing improvement in Ashworth Score over 6 hours post-dose for three groups: 16 mg tizanidine, 8 mg tizanidine, and placebo. The graph plots improvement on the vertical axis and hours post-dose on the horizontal axis, with error bars indicating variability at each time point.*

FDA Label Image

Ac68e443 89c9 42b1 Aa4c 66a32746d81e 04

A line graph showing improvement in Ashworth Score over time at 'End of Titration', 'End of Maintenance', and 'Endpoint' for tizanidine (mean dose 28.8 mg) versus placebo. The y-axis represents improvement in Ashworth Score, with tizanidine showing greater improvement (negative values) compared to placebo. Error bars indicate variability at each time point.*

FDA Label Image

Ac68e443 89c9 42b1 Aa4c 66a32746d81e 05

Tizanidine Hydrochloride 2 mg capsules label by Zydus Lifesciences Limited. The label states 150 capsules per container, Rx only. It includes a warning that the capsules are not interchangeable with tizanidine tablets or Zanaflex tablets. Storage instructions specify 20° to 25°C. Manufacturer is Cadila Healthcare Ltd., Ahmedabad, India.*

FDA Label Image

Ac68e443 89c9 42b1 Aa4c 66a32746d81e 06

Tizanidine Hydrochloride Capsules 4 mg by Zydus Lifesciences Limited. The label indicates this prescription medication pack contains 150 capsules. It includes storage instructions, a warning not to interchange with tizanidine tablets or Zanaflex tablets, and notes the product is manufactured by Cadila Healthcare Ltd., Ahmedabad, India. The NDC is 70771-1068-8.*

FDA Label Image

Ac68e443 89c9 42b1 Aa4c 66a32746d81e 07

Label for Tizanidine Hydrochloride Capsules, 6 mg strength, containing 150 capsules. The label includes an NDC number 70771-1069-8 and notes that the capsules contain 6 mg of tizanidine base per hard gelatin capsule. It has a warning stating the product is not interchangeable with tizanidine tablets or Zanaflex tablets. Manufactured by Cadila Healthcare Ltd, Matoda, Ahmedabad, India, and labeled by Zydus Lifesciences Limited. The label also includes storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.